Suppressing key protein may unlock immunotherapy for glioblastoma

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, suggests a way forward: suppressing a protein called ZNF638 triggers an antiviral immune response, making immune checkpoint inhibitors more effective.

How does education affect Alzheimer’s and dementia risk? It’s about more than degree attainment

Education has long been associated with reduced risk of Alzheimer’s disease and related dementias, but a new study reveals that this protection extends far beyond diplomas and degrees. Co-led by researchers at The University of Texas at Austin, the University of Minnesota, the University of Wisconsin-Madison and Columbia University, the study investigated how high school contexts, opportunities and outcomes shape midlife cognition even among people with the same completed degrees.

Virtual reality platform offers new hope for speech anxiety sufferers

The fear of public speaking is widely cited as being the most common fear. Furthermore, there is evidence to suggest that the prevalence of social anxiety and a fear of public speaking are both on the rise. This is concerning when one considers the range of known subsequent negative impacts on mental health, physical health, academic attainment, and career progression.